FATE THERAPEUTICS INC (FATE) Debt / Equity
- 2019-06-30: Debt/Equity Ratio 0.12.
- 2019-03-31: Debt/Equity Ratio 0.1.
- 2018-12-31: Debt/Equity Ratio 0.09.
- 2018-09-30: Debt/Equity Ratio 0.09.
Complete source-backed debt/equity ratio history.
- Available history
- 2012-12-31 to 2019-06-30
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|
| 2019-06-30 | 0.12 |
|---|
| 2019-03-31 | 0.1 |
|---|
| 2018-12-31 | 0.09 |
|---|
| 2018-09-30 | 0.09 |
|---|
| 2018-06-30 | 0.29 |
|---|
| 2018-03-31 | 0.23 |
|---|
| 2017-03-31 | 0.14 |
|---|
| 2016-12-31 | 0.15 |
|---|
| 2016-09-30 | 0.5 |
|---|
| 2016-06-30 | 0.63 |
|---|
| 2016-03-31 | 0.53 |
|---|
| 2015-12-31 | 0.48 |
|---|
| 2015-09-30 | 0.43 |
|---|
| 2015-06-30 | 0.39 |
|---|
| 2015-03-31 | 0.93 |
|---|
| 2014-12-31 | 0.69 |
|---|
| 2014-09-30 | 0.3 |
|---|
| 2013-12-31 | 0.07 |
|---|
| 2013-09-30 | -0.03 |
|---|
| 2012-12-31 | -0.07 |
|---|
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|
| 2018-12-31 | 0.09 |
|---|
| 2016-12-31 | 0.15 |
|---|
| 2015-12-31 | 0.48 |
|---|
| 2014-12-31 | 0.69 |
|---|
| 2013-12-31 | 0.07 |
|---|
| 2012-12-31 | -0.07 |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
|---|
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
|---|
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
|---|
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
|---|
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
|---|
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
|---|
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
|---|